rs749054531
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_021098.3(CACNA1H):c.5717C>T(p.Pro1906Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000129 in 1,551,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P1906P) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.5732C>T | p.Pro1911Leu | missense_variant | Exon 32 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.5735C>T | p.Pro1912Leu | missense_variant | Exon 32 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.5699C>T | p.Pro1900Leu | missense_variant | Exon 32 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.5732C>T | p.Pro1911Leu | missense_variant | Exon 33 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.5678C>T | p.Pro1893Leu | missense_variant | Exon 33 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.5699C>T | p.Pro1900Leu | missense_variant | Exon 32 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.5660C>T | p.Pro1887Leu | missense_variant | Exon 32 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.5699C>T | p.Pro1900Leu | missense_variant | Exon 32 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.5717C>T | p.Pro1906Leu | missense_variant | Exon 33 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.5717C>T | non_coding_transcript_exon_variant | Exon 33 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*1669C>T | non_coding_transcript_exon_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*798C>T | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3568C>T | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5161C>T | non_coding_transcript_exon_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*691C>T | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*576C>T | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1329C>T | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*384C>T | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*384C>T | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.5699C>T | non_coding_transcript_exon_variant | Exon 32 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.5717C>T | non_coding_transcript_exon_variant | Exon 33 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.5717C>T | non_coding_transcript_exon_variant | Exon 33 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*833C>T | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*1669C>T | 3_prime_UTR_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*798C>T | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3568C>T | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5161C>T | 3_prime_UTR_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*691C>T | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*576C>T | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1329C>T | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*384C>T | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*384C>T | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*833C>T | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152106Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000128 AC: 2AN: 156450 AF XY: 0.0000120 show subpopulations
GnomAD4 exome AF: 0.00000857 AC: 12AN: 1399676Hom.: 0 Cov.: 33 AF XY: 0.0000101 AC XY: 7AN XY: 690630 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152106Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74276 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.5717C>T (p.P1906L) alteration is located in exon 33 (coding exon 32) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 5717, causing the proline (P) at amino acid position 1906 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hyperaldosteronism, familial, type IV Uncertain:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at